Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136180322> ?p ?o ?g. }
- W3136180322 endingPage "e977" @default.
- W3136180322 startingPage "e977" @default.
- W3136180322 abstract "To determine the potential association between infections and rituximab (RTX)-induced hypogammaglobulinemia among patients with CNS inflammatory diseases.We included in a prospective observational study all consecutive adults with aquaporin 4 (AQP4) or myelin oligodendrocyte glycoprotein (MOG) antibody-positive disorders treated with RTX. Dosing schedule was adapted to memory B-cell measurement.We included 48 patients (mean age 47 [SD: 14] years; 77% females; 31 AQP4 positive and 17 MOG positive). The median follow-up was 3.6 years (range: 0.9-8.1 years). The median number of RTX infusions was 8 (range: 2-14). The median dosing interval was 6 months (range: 1.7-13.7 months). Sixty-seven symptomatic infections (SIs) were observed in 26 of 48 (54%) patients, including 13 severe infections in 9 (19%). Urinary and lower respiratory tract infections were the most frequent, representing 42% and 21% of SI. At RTX onset, the immunoglobulin G (IgG) level was abnormal in 3 of 48 (6%) patients. After RTX, 15 (31%), 11 (23%), 3 (6%), and 0 of 48 patients showed sustained IgG level <7, <6, <4, and <2 g/L, respectively. On multivariate Cox proportional hazards analysis, the main variables explaining the risk of SI were the presence of urinary tract dysfunction (hazard ratio [HR] = 34, 95% CI 4-262, p < 0.001), the dosing intervals (HR = 0.98, 95% CI 0.97-0.99, p < 0.001), and the interaction between IgG level and urinary tract dysfunction (HR = 0.67, 95% CI 0.53-0.85, p < 0.005). IgG level <6 g/L during RTX was associated with male sex (HR = 4, 95% CI 1.4-11.4, p < 0.01) and previous immunosuppression (HR = 3.4, 95% CI 1.2-10, p < 0.05).RTX used as maintenance therapy in CNS inflammatory diseases is frequently associated with reduced IgG level and increases the infection risk of the most vulnerable patients." @default.
- W3136180322 created "2021-03-29" @default.
- W3136180322 creator A5014564718 @default.
- W3136180322 creator A5016857800 @default.
- W3136180322 creator A5042715126 @default.
- W3136180322 creator A5054006135 @default.
- W3136180322 creator A5064280060 @default.
- W3136180322 creator A5082429090 @default.
- W3136180322 creator A5083835205 @default.
- W3136180322 creator A5086435509 @default.
- W3136180322 creator A5091582045 @default.
- W3136180322 date "2021-03-15" @default.
- W3136180322 modified "2023-10-03" @default.
- W3136180322 title "Rituximab-Induced Hypogammaglobulinemia and Infections in AQP4 and MOG Antibody–Associated Diseases" @default.
- W3136180322 cites W1522374426 @default.
- W3136180322 cites W1967360492 @default.
- W3136180322 cites W2013176883 @default.
- W3136180322 cites W2130342500 @default.
- W3136180322 cites W2141111992 @default.
- W3136180322 cites W2147750230 @default.
- W3136180322 cites W2561881161 @default.
- W3136180322 cites W2565433170 @default.
- W3136180322 cites W2790223348 @default.
- W3136180322 cites W2791329038 @default.
- W3136180322 cites W2793755712 @default.
- W3136180322 cites W2889885328 @default.
- W3136180322 cites W2900348232 @default.
- W3136180322 cites W2947252334 @default.
- W3136180322 cites W2965001522 @default.
- W3136180322 cites W2977883158 @default.
- W3136180322 cites W2989102128 @default.
- W3136180322 cites W3034095681 @default.
- W3136180322 cites W3034725616 @default.
- W3136180322 cites W3036213479 @default.
- W3136180322 cites W3038088150 @default.
- W3136180322 cites W3045030255 @default.
- W3136180322 cites W3048238297 @default.
- W3136180322 doi "https://doi.org/10.1212/nxi.0000000000000977" @default.
- W3136180322 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8054961" @default.
- W3136180322 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33722933" @default.
- W3136180322 hasPublicationYear "2021" @default.
- W3136180322 type Work @default.
- W3136180322 sameAs 3136180322 @default.
- W3136180322 citedByCount "23" @default.
- W3136180322 countsByYear W31361803222021 @default.
- W3136180322 countsByYear W31361803222022 @default.
- W3136180322 countsByYear W31361803222023 @default.
- W3136180322 crossrefType "journal-article" @default.
- W3136180322 hasAuthorship W3136180322A5014564718 @default.
- W3136180322 hasAuthorship W3136180322A5016857800 @default.
- W3136180322 hasAuthorship W3136180322A5042715126 @default.
- W3136180322 hasAuthorship W3136180322A5054006135 @default.
- W3136180322 hasAuthorship W3136180322A5064280060 @default.
- W3136180322 hasAuthorship W3136180322A5082429090 @default.
- W3136180322 hasAuthorship W3136180322A5083835205 @default.
- W3136180322 hasAuthorship W3136180322A5086435509 @default.
- W3136180322 hasAuthorship W3136180322A5091582045 @default.
- W3136180322 hasBestOaLocation W31361803221 @default.
- W3136180322 hasConcept C126322002 @default.
- W3136180322 hasConcept C159654299 @default.
- W3136180322 hasConcept C203014093 @default.
- W3136180322 hasConcept C207103383 @default.
- W3136180322 hasConcept C2777288759 @default.
- W3136180322 hasConcept C2777805810 @default.
- W3136180322 hasConcept C2780653079 @default.
- W3136180322 hasConcept C44249647 @default.
- W3136180322 hasConcept C50382708 @default.
- W3136180322 hasConcept C71924100 @default.
- W3136180322 hasConcept C77411442 @default.
- W3136180322 hasConcept C90924648 @default.
- W3136180322 hasConceptScore W3136180322C126322002 @default.
- W3136180322 hasConceptScore W3136180322C159654299 @default.
- W3136180322 hasConceptScore W3136180322C203014093 @default.
- W3136180322 hasConceptScore W3136180322C207103383 @default.
- W3136180322 hasConceptScore W3136180322C2777288759 @default.
- W3136180322 hasConceptScore W3136180322C2777805810 @default.
- W3136180322 hasConceptScore W3136180322C2780653079 @default.
- W3136180322 hasConceptScore W3136180322C44249647 @default.
- W3136180322 hasConceptScore W3136180322C50382708 @default.
- W3136180322 hasConceptScore W3136180322C71924100 @default.
- W3136180322 hasConceptScore W3136180322C77411442 @default.
- W3136180322 hasConceptScore W3136180322C90924648 @default.
- W3136180322 hasIssue "3" @default.
- W3136180322 hasLocation W31361803221 @default.
- W3136180322 hasLocation W31361803222 @default.
- W3136180322 hasLocation W31361803223 @default.
- W3136180322 hasLocation W31361803224 @default.
- W3136180322 hasLocation W31361803225 @default.
- W3136180322 hasLocation W31361803226 @default.
- W3136180322 hasOpenAccess W3136180322 @default.
- W3136180322 hasPrimaryLocation W31361803221 @default.
- W3136180322 hasRelatedWork W1727188710 @default.
- W3136180322 hasRelatedWork W2088206352 @default.
- W3136180322 hasRelatedWork W2119154902 @default.
- W3136180322 hasRelatedWork W2133235702 @default.
- W3136180322 hasRelatedWork W2135028155 @default.
- W3136180322 hasRelatedWork W2203903734 @default.
- W3136180322 hasRelatedWork W2904476754 @default.